Sanara Medtech Stock Forward View - Accumulation Distribution
| SMTI Stock | USD 20.38 0.00 0.00% |
Sanara Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Sanara Medtech's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 5th of February 2026 the relative strength index (rsi) of Sanara Medtech's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.12) | EPS Estimate Current Year (1.56) | EPS Estimate Next Year 0.475 | Wall Street Target Price 40 | EPS Estimate Current Quarter (0.21) |
Using Sanara Medtech hype-based prediction, you can estimate the value of Sanara Medtech from the perspective of Sanara Medtech response to recently generated media hype and the effects of current headlines on its competitors.
Sanara Medtech after-hype prediction price | USD 20.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Sanara Medtech to cross-verify your projections. Sanara Medtech Additional Predictive Modules
Most predictive techniques to examine Sanara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sanara using various technical indicators. When you analyze Sanara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 0.0916 | 0.0914 |
| Check Sanara Medtech Volatility | Backtest Sanara Medtech | Information Ratio |
Sanara Medtech Trading Date Momentum
| On February 05 2026 Sanara Medtech was traded for 20.38 at the closing time. The top price for the day was 22.43 and the lowest listed price was 20.38 . There was no trading activity during the period 0.0. Lack of trading volume on February 5, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Sanara Medtech to competition |
Other Forecasting Options for Sanara Medtech
For every potential investor in Sanara, whether a beginner or expert, Sanara Medtech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sanara Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sanara. Basic forecasting techniques help filter out the noise by identifying Sanara Medtech's price trends.Sanara Medtech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanara Medtech stock to make a market-neutral strategy. Peer analysis of Sanara Medtech could also be used in its relative valuation, which is a method of valuing Sanara Medtech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sanara Medtech Market Strength Events
Market strength indicators help investors to evaluate how Sanara Medtech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sanara Medtech shares will generate the highest return on investment. By undertsting and applying Sanara Medtech stock market strength indicators, traders can identify Sanara Medtech entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0914 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 21.41 | |||
| Day Typical Price | 21.06 | |||
| Market Facilitation Index | 2.05 | |||
| Price Action Indicator | (1.03) |
Sanara Medtech Risk Indicators
The analysis of Sanara Medtech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sanara Medtech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sanara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.88 | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.69 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Sanara Medtech
The number of cover stories for Sanara Medtech depends on current market conditions and Sanara Medtech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sanara Medtech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sanara Medtech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sanara Medtech Short Properties
Sanara Medtech's future price predictability will typically decrease when Sanara Medtech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sanara Medtech often depends not only on the future outlook of the potential Sanara Medtech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sanara Medtech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.5 M | |
| Cash And Short Term Investments | 15.9 M |
Check out Historical Fundamental Analysis of Sanara Medtech to cross-verify your projections. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is there potential for Health Care Equipment & Supplies market expansion? Will Sanara introduce new products? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Revenue Per Share | Quarterly Revenue Growth 0.215 | Return On Assets | Return On Equity |
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sanara Medtech's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.